Timothy Henn

Redwood City, California-based molecular diagnostics firm CardioDx has named Timothy Henn CFO. He most recently served as CFO of Crescendo Biosciences, which was acquired by Myriad Genetics in 2014. Henn has also held senior finance positions with Monogram Bioscience and Incyte.